Pneumonic plague

Seminars in Respiratory Infections

Volumn 18, Issue 3, 2003, Pages 159-167

  Krishna, Ganesh ^b   Chitkara, Rajinder K ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; KANAMYCIN; LIVE VACCINE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

AEROSOL; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; CLINICAL FEATURE; HEALTH CARE PERSONNEL; HUMAN; MORTALITY; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PATHOGENESIS; PLAGUE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; UNITED STATES; YERSINIA PESTIS;

ANTI-INFECTIVE AGENTS; BIOTERRORISM; HUMANS; PLAGUE; UNITED STATES; YERSINIA PESTIS;

EID: 0141506053     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Cole ST, Buchreiser C: Bacterial genomics: A plague o' both your hosts. Nature 413:467-470, 2001
2. Perry RD, Fetherston JD: Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10:35-66, 1997
3. Titball RW, Leary SEC: Plague. Br Med Bull 54:625-633, 1998
4. World Health Organization: Weekly epidemiological record. Human Plague in 1997. WHO 74:340-344, 1999
5. Barnes AM, Quan TJ: Plague, in Gorbach SL, Bartlett JG, Blacklow NR (eds): Infectious Diseases. Philadelphia, Saunders, 1992, pp 1285-1291
6. Dennis DT, Gage KL, Gratz N, et al: Plague manual: Epidemiology, distribution, surveillance and control. Geneva, Switzerland, World Health Organization (WHO/CDS/EDC/99.2), 2001, pp 1-171
7. Meyer KF: Pneumonic plague. Bacteriol Rev 25:249-261, 1961
8. Inglesby TV, Dennis DT, Henderson DA, et al: for the Working Group on Civilian Biodefense: Plague as a biological weapon: Medical and public health management (consensus statement). JAMA 283:2281-2290, 2000
9. Harris SH: Factories of death. New York, Routledge, 1994, pp 78-96
10. WHO Consultants: Health aspects of chemical and biological weapons. Geneva, Switzerland, World Health Organization, 1970, pp 98-109
11. Bercovier H, Mollaret HH: Genus XIV Yersinia van Loghem 1944, 15AL, in Kreig NR, Holt JG (eds): Bergey's Manual of Systemic Bacteriology. Baltimore, Williams & Wilkins, 1984, pp 498-506
12. Cleri DJ, Vernaleo JR, Lombardi LJ, et al: Plague pneumonia. Disease caused by Yersinia Pestis. Semin Respir Infect 12:12-23, 1997
13. Corbel MJ: Yersinia, in Parker MT, Collier LH (eds): Topley and Wilson's Principles of Bacteriology, Virology and Immunity. London, Edward Arnold, 1990, vol 2:pp 496-510
14. Koornhof HJ, Smego RA Jr, Nicol M: Yersiniosis II. The pathogenesis of Yersinia infections. Eur J Clin Microbiol Infect Dis 18:87-112, 1999
15. Straley S, Skrzypek E, Piano GV, et al: Yops of Yersinia spp pathogenic to humans. Infect Immun 61:3105-3110, 1993
16. Smego RA, Frean J, Koornhof HJ: Yersiniosis I: Microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis 18:1-15, 1999
17. Guiyoule A, Grimont F, Iteman I, et al: Plague pandemics investigated by ribotyping of Yersinia pestis strains. J Clin Microbiol 32:634-641, 1994
18. Cowan C, Jones HA, Kaya YH, et al: Invasion of epithelial cells by Yersinia pestis: Evidence for an Y. pestis-specific invasion. Infect Immun 68:4523-4530, 2000
19. Parkhill J, Wren BW, Thomson NR, et al: Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413:523-527, 2001
20. Hinnebusch J: Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice. Int J Med Microbiol 290:483-487, 2000
21. Manson-Bahr PEC, Apted FIC: Plague and melioidosis, in Cook G (ed): Manson's Tropical Diseases (ed 18). London, Bailliere Tindall, 1982, pp 331-347
22. Butler T: Plague and other Yersinia infections. New York, Plenum Medical Book Company, 1983
23. Goldstein MD: Plague (Yersinia Pestis), in Feigin RD, Cherry JD (eds): Textbook of Pediatric Infectious Diseases. ed 3. Philadelphia, Saunders, 1992, pp 1218-1222
24. Butler T: Yersinia species (including plague), in Mandell GL, Bennett JE, Dolin R (eds): Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. ed 4. New York, Churchill Livingstone, 1995, pp 2070-2078
25. Campbell GL, Dennis DT: Plague and other Yersinia infections, in Fauci AS, Braunwald E, Isselbacher KJ, et al: (eds): Harrison's Principles of Internal Medicine. New York, McGraw-Hill, 1998, pp 975-983
26. Centers for Disease Control and Prevention: Fatal human plague. MMWR Morb Mortal Wkly Rep 278:380-382, 1997
27. Werner SB, Weidmer CE, Nelson BC, et al: Primary plague pneumonia contracted from a domestic cat in South Lake Tahoe, California. JAMA 251:929-931, 1984
28. Russell M, Nelson M, Whittington M, et al: Laboratory diagnosis of plague. Br J Biomed Sci 54:231-236, 1997
29. Martin GJ, Marty AM: Clinicopathologic aspects of bacterial agents. Clin Lab Med 3:513-548, 2001
30. Araujo AM, Petribu' ATS, Barbosa JRP, et al: Rapid ELISA for plague. Mem Inst Oswaldo Cruz 93:111-112, 1998
31. Chanteau S, Rahalison L, Ratsitorahina M, et al: Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick. Int J Med Microbiol 290:279-283, 2000
32. Cao LK, Anderson GP, Ligler FS, et al: Detection of Yersinia pestis fraction 1 antigen with a fiber optic biosensor. J Clin Microbiol 33:336-341, 1995
33. Krishnamurthy T, Ross PL, Rajamani U: Detection of pathogenic and non-pathogenic bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 10:883-888, 1996
34. Feodorova VA, Devdariani ZL: Development, characterization and diagnostic application of monoclonal antibodies against Yersinia pestis fibrinolysin and coagulase. Diagn Microbiol 49:261-269, 2000
35. Tsukano H, Itoh K, Suzuki S, et al: Detection and identification of Yersinia pestis by polymerase chain reaction (PCR) using multiplex primers. Clin Microbiol 35:886-891, 1997
36. Higgins JA, Ezzell J, Hinnebusch J, et al: 5′ nuclease PCR assay to detect Yersinia pestis. J Clin Microbiol 36:2284-2288, 1998
37. Garner JS: Hospital infection control practices. Advisory committee guidelines for isolation precautions in hospitals. Infect Cont Hosp Epidemiol 17:53-80, 1996
38. Rosenbloom M, Leikin JB, Vogel SN, et al: Biological and chemical agents: A brief synopsis. Am J Ther 9:5-14, 2002
39. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 340:207-214, 1999
40. Carus WS: Bioterrorism and biocrimes: The illicit use of biological agents in the 20th century. Washington, DC, Center for Counter Proliferation Research, National Defense University, 1998
41. Byrne WR, Welkos SL, Pitt ML: Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother 42:675-681, 1998
42. Wu LT: A treatise on pneumonic plague. Geneva, Switzerland, League of Nations Health Organization, 1926
43. Chernin E: Richard Pearson strong and the Manchurian epidemic of pneumonic plague, 1910-1911. J Hist Med Allied Sci 44:296-319, 1989
44. American Public Health Association: Plague, in Benenson AS, (ed): Control of Communicable Diseases Manual. Washington, DC, American Public Health Association, 1995, pp 353-358